U
Veradermics, Incorporated MANE
NYSE
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

12/31/2024
Total Cash And Short-Term Investments 53.08M
Total Receivables 1.38M
Inventory --
Prepaid Expenses 1.04M
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets 38.00K
Total Current Assets 55.54M

Total Current Assets 55.54M
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets --
Total Assets 55.54M

Total Accounts Payable 2.25M
Total Accrued Expenses 2.47M
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities --
Total Other Current Liabilities --
Total Current Liabilities 4.72M

Total Current Liabilities 4.72M
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 4.72M

Common Stock & APIC 751.00K
Retained Earnings -49.23M
Treasury Stock & Other -3.85M
Total Common Equity -52.33M

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 103.15M
Preferred Stock, Others --
Total Preferred Equity 103.15M

Total Common Equity -52.33M
Total Preferred Equity 103.15M
Total Minority Interest --
Total Equity 50.82M